Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/13/11 → 12/31/16 |
Funding
- Merck Sharp and Cohme Corporation ( Award # ): $91,750.00
Protocol No.: V212-011; "A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy"
- Markowitz, Avi (PI)
Project: Research project